<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Niva Bupa Health Insurance Company Ltd. (NIVABUPA) — Tipsheet</title>
    <link>https://tipsheet.markets/company/nivabupa/</link>
    <atom:link href="https://tipsheet.markets/company/nivabupa/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Niva Bupa Health Insurance Company Ltd. (NIVABUPA), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Mon, 06 Jul 2026 10:22:48 GMT</lastBuildDate>
    <item>
      <title>Niva Bupa&#39;s chairman exits on health grounds; ex-SBI MD to replace him</title>
      <link>https://tipsheet.markets/nivabupa-niva-bupa-s-chairman-exits-on-health-grounds-ex-sbi-md-to-replace-him-105098/</link>
      <guid isPermaLink="true">https://tipsheet.markets/nivabupa-niva-bupa-s-chairman-exits-on-health-grounds-ex-sbi-md-to-replace-him-105098/</guid>
      <pubDate>Wed, 03 Jun 2026 15:16:09 GMT</pubDate>
      <description>Milind Barve steps down effective June 2026. The board has named former SEBI member Ashwani Bhatia as his successor, pending shareholder and IRDAI approval.</description>
      <content:encoded><![CDATA[<p><em>Milind Barve steps down effective June 2026. The board has named former SEBI member Ashwani Bhatia as his successor, pending shareholder and IRDAI approval.</em></p>
<h3>What’s new</h3><ul><li>Chairman and independent director Milind Barve is resigning due to health issues.</li><li>The board has named Ashwani Bhatia as his replacement, pending shareholder and IRDAI approval.</li><li>Bhatia is a former SEBI whole-time member and former managing director of State Bank of India.</li></ul>
<h3>Why it matters</h3><p>The change brings a heavyweight former regulator and banker to the chair of a mid-cap health insurer. Bhatia's background at SEBI and SBI adds governance heft, though the move is triggered by health issues, not strategy. No financial surprise here, but the board gains a member with deep regulatory experience.</p>
<h3>What we’re watching</h3><ul><li>The timeline and outcome of shareholder and IRDAI approval for Bhatia.</li><li>Any shift in governance posture under the new chairman.</li><li>Whether the change alters the company's regulatory or capital-raising ambitions.</li></ul>
<h3>The full read</h3><p>Niva Bupa's chairman Milind Barve is out on health grounds. His replacement, Ashwani Bhatia, is a former <strong>SEBI</strong> whole-time member and <strong>SBI</strong> managing director. The appointment is pending shareholder and <strong>IRDAI</strong> approval. For a mid-cap health insurer, landing a chairman with that pedigree is a governance upgrade, even if the trigger is personal. The move adds regulatory and banking weight to a company operating in one of India's most scrutinized sectors. No financial ripple here. The story is about who sits at the top of the board.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544286&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=NIVABUPA">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>